RadNet Income After Taxes 2010-2024 | RDNT

RadNet income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
RadNet Annual Income After Taxes
(Millions of US $)
2023 $30
2022 $34
2021 $44
2020 $-2
2019 $23
2018 $38
2017 $2
2016 $8
2015 $9
2014 $2
2013 $2
2012 $60
2011 $7
2010 $-18
2009 $-7
RadNet Quarterly Income After Taxes
(Millions of US $)
2024-06-30 $7
2024-03-31 $5
2023-12-31 $6
2023-09-30 $24
2023-06-30 $15
2023-03-31 $-14
2022-12-31 $5
2022-09-30 $6
2022-06-30 $14
2022-03-31 $8
2021-12-31 $1
2021-09-30 $21
2021-06-30 $8
2021-03-31 $14
2020-12-31 $11
2020-09-30 $10
2020-06-30 $-9
2020-03-31 $-14
2019-12-31 $13
2019-09-30 $5
2019-06-30 $8
2019-03-31 $-2
2018-12-31 $31
2018-09-30 $6
2018-06-30 $6
2018-03-31 $-5
2017-12-31 $-7
2017-09-30 $4
2017-06-30 $6
2017-03-31 $-1
2016-12-31 $4
2016-09-30 $2
2016-06-30 $3
2016-03-31 $-1
2015-12-31 $1
2015-09-30 $8
2015-06-30 $4
2015-03-31 $-4
2014-12-31 $4
2014-09-30 $5
2014-06-30 $5
2014-03-31 $-12
2013-12-31 $1
2013-09-30 $-0
2013-06-30 $3
2013-03-31 $-1
2012-12-31 $53
2012-09-30 $5
2012-06-30 $3
2012-03-31 $-1
2011-12-31 $8
2011-09-30 $-1
2011-06-30 $2
2011-03-31 $-2
2010-12-31 $5
2010-09-30 $-3
2010-06-30 $-14
2010-03-31 $-6
2009-12-31 $2
2009-09-30 $-3
2009-06-30 $-3
2009-03-31 $-3
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.963B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Chemed (CHE) United States $8.694B 26.73
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00